90
Views
4
CrossRef citations to date
0
Altmetric
Original Research

Antifungal efficacy of itraconazole-loaded TPGS-b-(PCL-ran-PGA) nanoparticles

, , , , , & show all
Pages 1415-1423 | Published online: 17 Feb 2015

References

  • PaganoLAkovaMDimopoulosGHerbrechtRDrgonaLBlijlevensNRisk assessment and prognostic factors for mould-related diseases in immunocompromised patientsJ Antimicrob Chemother201166Suppl 1i5i1421177404
  • EnochDALudlamHABrownNMInvasive fungal infections: a review of epidemiology and management optionsJ Med Microbiol200655Pt 780981816772406
  • JungSHLimDHJungSHAmphotericin B-entrapping lipid nanoparticles and their in vitro and in vivo characteristicsEur J Pharm Sci2009373–431332019491021
  • OddsFCBrownAJGowNAAntifungal agents: mechanisms of actionTrends Microbiol200311627227912823944
  • SabatelliFPatelRMannPAIn vitro activities of posaconazole, fluconazole, itraconazole, voriconazole, and amphotericin B against a large collection of clinically important molds and yeastsAntimicrob Agents Chemother20065062009201516723559
  • PandaNKItraconazole – a potent antifungal drugIndian J Otolaryngol Head Neck Surg199749329329423119315
  • WillemsLvan der GeestRde BeuleKItraconazole oral solution and intravenous formulations: a review of pharmacokinetics and pharmacodynamicsJ Clin Pharm Ther200126315916911422598
  • PeetersJNeeskensPTollenaereJPVan RemoorterePBrewsterMECharacterization of the interaction of 2-hydroxypropyl-b-cyclodextrin with itraconazole at pH 2, 4, and 7J Pharm Sci20029161414142212115841
  • De BeuleKItraconazole: pharmacology, clinical experience and future developmentInt J Antimicrob Agents19966317518118611706
  • AkkarAMüllerRHIntravenous itraconazole emulsions produced by SolEmuls technologyEur J Pharm Biopharm2003561293612837478
  • ChenWGuBWangHPanJLuWHouHDevelopment and evaluation of novel itraconazole-loaded intravenous nanoparticlesInt J Pharm20083621–213314018585448
  • YiYYoonHJKimBOA mixed polymeric micellar formulation of itraconazole: characteristics, toxicity and pharmacokineticsJ Control Release20071171596717097755
  • GouldSScottRC2-Hydroxypropyl-beta-cyclodextrin (HP-beta-CD): a toxicology reviewFood Chem Toxicol200543101451145916018907
  • PanyamJLabhasetwarVBiodegradable nanoparticles for drug and gene delivery to cells and tissueAdv Drug Deliv Rev200355332934712628320
  • MundargiRCSrirangarajanSAgnihotriSADevelopment and evaluation of novel biodegradable microspheres based on poly(d,l-lactide-co-glycolide) and poly(epsilon-caprolactone) for controlled delivery of doxycycline in the treatment of human periodontal pocket: in vitro and in vivo studiesJ Control Release20071191596817331611
  • VertMDegradable and bioresorbable polymers in surgery and in pharmacology: beliefs and factsJ Mater Sci Mater Med200920243744618815731
  • AndrianoKPDanielsAUSmutzWPWyattRWPreliminary biocompatibility screening of several biodegradable phosphate fiber reinforced polymersJ Appl Biomater19934111210148351
  • SunHMeiLSongCCuiXWangPThe in vivo degradation, absorption and excretion of PCL-based implantBiomaterials20062791735174016198413
  • HuangLChenHZhengYNanoformulation of d-α-tocopheryl polyethylene glycol 1000 succinate-b-poly(ε-caprolactone-ran-glycolide) diblock copolymer for breast cancer therapyIntegr Biol (Camb)2011310993100221938302
  • MatsumuraYKataokaKPreclinical and clinical studies of anticancer agent-incorporating polymer micellesCancer Sci2009100457257919462526
  • RuanGFengSSLiQTEffects of material hydrophobicity on physical properties of polymeric microspheres formed by double emulsion processJ Control Release200284315116012468218
  • MuLFengSSVitamin E TPGS used as emulsifier in the solvent evaporation/extraction technique for fabrication of polymeric nanospheres for controlled release of paclitaxel (Taxol)J Control Release2002801–312914411943393
  • MainardesRMEvangelistaRCPLGA nanoparticles containing praziquantel: effect of formulation variables on size distributionInt J Pharm20052901–213714415664139
  • PatelNRDamannKLeonardiCSabliovCMItraconazole-loaded poly(lactic-co-glycolic) acid nanoparticles for improved antifungal activityNanomedicine (Lond)2010571037105020874019
  • PachecoPVenturaASBrancoTGonçalvesLCarvalhoCClinical experience in invasive fungal infectionsClin Drug Investig201333Suppl 1S23S26
  • GazzoniFFSeveroLCMarchioriEFungal diseases mimicking primary lung cancer: radiologic-pathologic correlationMycoses201457419720824147761
  • BorakBBiernatPPreschaABaszczukAPlutaJIn vivo study on the biodistribution of silica particles in the bodies of ratsAdv Clin Exp Med2012211131823214294
  • WanakulePLiuGWFleuryATRoyKNano-inside-micro: disease-responsive microgels with encapsulated nanoparticles for intracellular drug delivery to the deep lungJ Control Release2012162242943722841795